Innovative Technology Sommetrics utilizes its patented aer+ technology to develop non-invasive airway management solutions, positioning it as a leader in comfortable sleep and airway treatment devices that could appeal to clinics seeking advanced, patient-friendly equipment.

FDA Breakthrough Status The company’s aerSleep II device has received FDA Breakthrough Device designation, indicating a potential for accelerated adoption and funding opportunities within healthcare institutions looking for innovative sleep apnea treatments.

Recent Clinical Advancements With the launch of pivotal clinical trials for aerSleep II, Sommetrics demonstrates ongoing product refinement and validation, providing potential for expanding sales as new data supports wider clinical use.

Growth and Recognition Awarded the Frost & Sullivan 2018 Visionary Innovation Leadership Award, the company's reputation for innovation in airway management enhances its credibility, making it attractive for partnerships and institutional customers.

Strong Funding & Market Focus Having secured $12 million in funding and generating revenues up to $10 million, Sommetrics shows financial stability and growth potential, presenting opportunities for sales expansion into sleep clinics, hospitals, and medical device distributors.